Docena, G <br/><br/>
Down-regulation of p38 mitogen-activated protein kinase activation and proinflammatory cytokine production by mitogen-activated protein kinase inhibitors in inflammatory bowel disease.  [electronic resource] 

 -  Clinical and experimental immunology  Oct 2010 
 - 108-15 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2249 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2249.2010.04203.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Blotting, Western<br/>Cells, Cultured<br/>Cytokines--metabolism<br/>Down-Regulation--drug effects<br/>Enzyme Activation--drug effects<br/>Enzyme Inhibitors--pharmacology<br/>Female<br/>Humans<br/>Imidazoles--pharmacology<br/>Inflammation Mediators--metabolism<br/>Inflammatory Bowel Diseases--enzymology<br/>Interleukin-1beta--metabolism<br/>Interleukin-6--metabolism<br/>Intestinal Mucosa--drug effects<br/>Male<br/>Middle Aged<br/>Niacinamide--pharmacology<br/>Organ Culture Techniques<br/>Phosphorylation--drug effects<br/>Pyridines--pharmacology<br/>Pyrimidines--pharmacology<br/>Tumor Necrosis Factor-alpha--metabolism<br/>Young Adult<br/>p38 Mitogen-Activated Protein Kinases--antagonists & inhibitors